Correlation Between Lyra Therapeutics and CytomX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and CytomX Therapeutics, you can compare the effects of market volatilities on Lyra Therapeutics and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and CytomX Therapeutics.
Diversification Opportunities for Lyra Therapeutics and CytomX Therapeutics
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Lyra and CytomX is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and CytomX Therapeutics go up and down completely randomly.
Pair Corralation between Lyra Therapeutics and CytomX Therapeutics
Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the CytomX Therapeutics. In addition to that, Lyra Therapeutics is 2.04 times more volatile than CytomX Therapeutics. It trades about -0.08 of its total potential returns per unit of risk. CytomX Therapeutics is currently generating about -0.13 per unit of volatility. If you would invest 120.00 in CytomX Therapeutics on August 28, 2024 and sell it today you would lose (24.00) from holding CytomX Therapeutics or give up 20.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 97.67% |
| Values | Daily Returns |
Lyra Therapeutics vs. CytomX Therapeutics
Performance |
| Timeline |
| Lyra Therapeutics |
| CytomX Therapeutics |
Lyra Therapeutics and CytomX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyra Therapeutics and CytomX Therapeutics
The main advantage of trading using opposite Lyra Therapeutics and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
| CytomX Therapeutics vs. Eliem Therapeutics | CytomX Therapeutics vs. HCW Biologics | CytomX Therapeutics vs. Scpharmaceuticals | CytomX Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |